Long Zhang, Yu Chen, Xueqing Shi, Taifeng Zhou, Jie Han, Lin Meng, Na Li, Matthew B. Greenblatt, Zemin Ling, Peiqiang Su, Fuxin Wei, Ren Xu
{"title":"Discovery of a peripheral Myh11-expressing nucleus pulposus cell population demontrating therapeutic potential for disc degeneration","authors":"Long Zhang, Yu Chen, Xueqing Shi, Taifeng Zhou, Jie Han, Lin Meng, Na Li, Matthew B. Greenblatt, Zemin Ling, Peiqiang Su, Fuxin Wei, Ren Xu","doi":"10.1038/s41467-026-76515-2","DOIUrl":null,"url":null,"abstract":"Continual turnover of nucleus pulposus (NP) cellularity is critical for maintaining intervertebral disc (IVD) homeostasis; however, the presence and identity of potential progenitor cells within the NP remain unclear. This study identifies NP cells expressing myosin heavy chain 11 (Myh11+ NPCs) through single-cell transcriptomic analysis of human adolescent NP cells and spatial transcriptomic mapping of the murine juvenile IVD. Lineage tracing reveals that a limited population of peripheral Myh11+ NPCs emerges during embryogenesis and contributes persistently to NP maturation, homeostasis, and aging in mice. Myh11+ NPCs exhibit sphere-forming capacity and multipotent differentiation potential in vitro. Consistent with these findings, inducible ablation of Myh11+ NPCs using a diphtheria toxin subunit alpha gene (DTA) system result in IVD degeneration. Therapeutically, either Myh11-specific deletion of nerve growth factor receptor (Ngfr) or transplantation of Myh11+ NPCs into injured NP tissues mitigates pathological progression in a mouse model of IVD degeneration. In conclusion, these findings identify a potential marker that delineates the this NPCs population with progenitor cells characteristics in both mice and humans, thereby facilitating the development of targeted therapeutic strategies for spinal disorders focused on this cell population.","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"4 1","pages":""},"PeriodicalIF":18.1000,"publicationDate":"2026-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Communications","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1038/s41467-026-76515-2","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Continual turnover of nucleus pulposus (NP) cellularity is critical for maintaining intervertebral disc (IVD) homeostasis; however, the presence and identity of potential progenitor cells within the NP remain unclear. This study identifies NP cells expressing myosin heavy chain 11 (Myh11+ NPCs) through single-cell transcriptomic analysis of human adolescent NP cells and spatial transcriptomic mapping of the murine juvenile IVD. Lineage tracing reveals that a limited population of peripheral Myh11+ NPCs emerges during embryogenesis and contributes persistently to NP maturation, homeostasis, and aging in mice. Myh11+ NPCs exhibit sphere-forming capacity and multipotent differentiation potential in vitro. Consistent with these findings, inducible ablation of Myh11+ NPCs using a diphtheria toxin subunit alpha gene (DTA) system result in IVD degeneration. Therapeutically, either Myh11-specific deletion of nerve growth factor receptor (Ngfr) or transplantation of Myh11+ NPCs into injured NP tissues mitigates pathological progression in a mouse model of IVD degeneration. In conclusion, these findings identify a potential marker that delineates the this NPCs population with progenitor cells characteristics in both mice and humans, thereby facilitating the development of targeted therapeutic strategies for spinal disorders focused on this cell population.
期刊介绍:
Nature Communications, an open-access journal, publishes high-quality research spanning all areas of the natural sciences. Papers featured in the journal showcase significant advances relevant to specialists in each respective field. With a 2-year impact factor of 16.6 (2022) and a median time of 8 days from submission to the first editorial decision, Nature Communications is committed to rapid dissemination of research findings. As a multidisciplinary journal, it welcomes contributions from biological, health, physical, chemical, Earth, social, mathematical, applied, and engineering sciences, aiming to highlight important breakthroughs within each domain.